Renal outcomes with different fixed-dose combination therapies in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH): a prespecified secondary analysis of a randomised controlled trial
George L. BakrisHypertensive Diseases Unit, Department of Medicine, University of Chicago-Pritzker School of Medicine, Chicago, IL 60637, USA. [email protected]Pantelis SarafidisAHEPA University HospitalMatthew R WeirUniversity of Maryland School of Medicine, Baltimore, MD, USABjörn DahlöfSahlgrenska University Hospital, Gothenburg, SwedenBertram PittUniversity of Michigan Health System, Ann Arbor, MI, USAKenneth JamersonUniversity of Michigan Health System, Ann Arbor, MI, USAEric J. VelazquezDuke University School of Medicine, Durham, NC, USALinda Staikos-ByrneNovartis Pharmaceuticals Corporation, East Hanover, NJ, USARoxzana Y. KellyNovartis Pharmaceuticals Corporation, East Hanover, NJ, USAVictor ShiNovartis Pharmaceuticals Corporation, East Hanover, NJ, USAYannTong ChiangNovartis Pharmaceuticals Corporation, East Hanover, NJ, USAMichael A. WeberSUNY Downstate Medical College, Brooklyn, NY, USA
2010en
ABI
Аннотация
Аннотация мавжуд эмас.
Идентификаторлар
Иқтибослар ва манбалар
2 та иқтибос0 та фойдаланилган манба